Another proof was found that the Indian vaccine is safe, top government committee said - it does not cause blood clotting.

The top government committee set up to investigate the side effects of Indian vaccine conviction and covishield has proved that clotting does not clot in the blood after taking Covaxin and covicshield. The committee conducted an in-depth analysis of the health of 400 adversely affected people under the government-run vaccination drive, after which it was found that these vaccines do not cause any clot in the blood. The committee has submitted its report to the senior government official.

Reported trial of 412 people with side effects

Dr. NK Arora, executive director of Incline Trust and National Adviser Event Following Immunization (NEFE), looking into the matter, said that such a case has been analyzed. He said that there is no unnatural bleeding or blood clot after the dose lane of Covishield or Covaxin. Dr. Arora said that out of those who took the vaccine, 412 such cases were analyzed in which after taking the vaccine dose, there was some adverse effect on the person. In these cases, the person had to be taken to hospital while in some cases the person also died. In the end, the committee's experts found that none of these cases were the case in which a person's blood flow or blood clot has formed due to taking a vaccine dose.

Expert groups keep a close watch on people with side effects

This conclusion was presented to the National Expert Group on Vaccine Administration (NEGVAC) and GACVS for Covid 19. Dr. Arora said that all the cases of adversarial effects are coming, all of them are being closely monitored. At a time when the pace of vaccination is being accelerated, the state and central government identify people with severe AEFIs with better coordination and conduct all their tests very quickly. NEGVAC keeps an eye on all these matters. He said that we make sure that all the cases with adversarial effects are found, within two to three weeks, find out their causes.

Indian vaccine being tested abroad

Given the side effects of the Astra Zeneca vaccine developed by Oxford University, the risk of Indian vaccine Covax is being tested in many countries. Because Covishield is also made on the lines of the AstraZeneca vaccine. The dose of the Astra Genica vaccine has been postponed in the Netherlands, Thailand, Norway, Denmark, Ireland, Iceland, Bulgaria, Luxembourg, Lithuania, Estonia, and Latvia due to the security risk. However, the WHO and the European Medicines Authority's Safety Committee had said last week that based on the available data, we cannot say that taking the vaccine causes blood clotting.